Terra Innovatum and GSR III Acquisition Corp. Announce Effectiveness of S-4 and Set Extraordinary General Meeting Date to Approve Business Combination
Terra Innovatum, a micro-modular nuclear reactor developer, and GSR III Acquisition Corp. (NASDAQ: GSRT) announced that the SEC has declared effective their S-4 registration statement for their proposed business combination. The companies have scheduled an Extraordinary General Meeting for October 7, 2025 to approve the merger.
Terra Innovatum has made significant progress, including securing MOUs for nuclear component supply and manufacturing, selecting their first deployment site, and advancing with NRC procedures. The record date for shareholder voting is September 15, 2025, and the GSRT Board unanimously recommends voting "FOR" all proposals.
The virtual meeting will be held at 11:00 AM ET via webcast, with the business combination expected to close shortly after approval, subject to closing conditions.Terra Innovatum, uno sviluppatore di reattori nucleari micro-modulari, e GSR III Acquisition Corp. (NASDAQ: GSRT) hanno annunciato che la SEC ha dichiarato efficace la loro dichiarazione di registrazione S-4 per la proposta fusione. Le società hanno pianificato un Assemblea Generale Straordinaria per il 7 ottobre 2025 per approvare la fusione.
Terra Innovatum ha fatto progressi significativi, tra cui assicurare MOUs per la fornitura e la produzione di componenti nucleari, selezionare il primo sito di dispiegamento e avanzare nelle procedure NRC. La data di registrazione per l’elezione degli azionisti è il 15 settembre 2025, e il Consiglio di GSRT raccomanda all’unanimità di votare "A FAVORE" tutte le proposte.
La riunione virtuale si terrà alle 11:00 ET via webcast, con l’insieme delle operazioni di fusione previsto a chiudersi poco dopo l’approvazione, soggetta alle condizioni di chiusura.
Terra Innovatum, un desarrollador de reactores nucleares micro-modulares, y GSR III Acquisition Corp. (NASDAQ: GSRT) anunciaron que la SEC ha declarado efectiva su declaración de registro S-4 para su propuesta de combinación de negocios. Las empresas han programado una Junta General Extraordinaria para el 7 de octubre de 2025 para aprobar la fusión.
Terra Innovatum ha logrado avances significativos, incluyendo asegurar MOUs para el suministro y la fabricación de componentes nucleares, seleccionar su primer sitio de implementación y avanzar con los procedimientos de NRC. La fecha de registro para la votación de los accionistas es el 15 de septiembre de 2025, y la Junta de GSRT recomienda por unanimidad votar "A FAVOR" de todas las propuestas.
La reunión virtual se llevará a cabo a las 11:00 AM ET vía webcast, y se espera que la fusión se cierre poco después de la aprobación, sujeta a las condiciones de cierre.
Terra Innovatum, 마이크로 모듈형 원자로 개발업체, 및 GSR III Acquisition Corp. (NASDAQ: GSRT)은 SEC가 그들의 S-4 등록신고서를 발효로 선언했다고 발표했다. 양사는 합병 승인을 위한 주주총회를 2025년 10월 7일에 개최하기로 했다.
Terra Innovatum은 핵 부품 공급 및 제조를 위한 MOU 확보, 최초 배치 사이트 선정, NRC 절차 진행 등 상당한 진전을 이루었다. 주주 의결의 기준일은 2025년 9월 15일이며 GSRT 이사회는 만장일치로 모든 제안에 찬성 표를 권고한다.
가상 회의는 동부 표준시 기준 오전 11시에 개최되며, 승인이 된 이후 합병은 마감 조건에 따라 곧 종결될 것으로 예상된다.
Terra Innovatum, un développeur de réacteurs nucléaires micro-modulaires, et GSR III Acquisition Corp. (NASDAQ: GSRT) ont annoncé que la SEC a déclaré efficace leur déclaration d’enregistrement S-4 pour leur fusion envisagée. Les sociétés ont prévu une Assemblée générale extraordinaire pour le 7 octobre 2025 afin d’approuver la fusion.
Terra Innovatum a réalisé des progrès significatifs, notamment en sécurisant des MoU pour l’approvisionnement et la fabrication de composants nucléaires, en sélectionnant leur premier site de déploiement et en avançant dans les procédures de la NRC. La date d’enregistrement pour le vote des actionnaires est le 15 septembre 2025, et le conseil d’administration de GSRT recommande à l’unanimité de voter « POUR » toutes les propositions.
La réunion virtuelle se tiendra à 11h00 ET par webcast, la fusion devant être conclue peu après l’approbation, sous réserve des conditions de clôture.
Terra Innovatum, ein Entwickler von mikromodularen Kernreaktoren, und GSR III Acquisition Corp. (NASDAQ: GSRT) gaben bekannt, dass die SEC ihre S-4-Registrierungsanmeldung für die vorgeschlagene Geschäftszuammenführung für wirksam erklärt hat. Die Unternehmen haben eine Außerordentliche Generalversammlung für den 7. Oktober 2025 anberaumt, um die Fusion zu genehmigen.
Terra Innovatum hat erhebliche Fortschritte gemacht, darunter MOUs für die Lieferung und Herstellung von Nuklearkomponenten sichern, ihren ersten Einsatzstandort auswählen und mit NRC-Verfahren voranschreiten. Das Aufzeichnungsdatum für die Abstimmung der Aktionäre ist der 15. September 2025, und der GSRT-Vorstand empfiehlt einstimmig für alle Vorschläge zu stimmen.
Die virtuelle Sitzung wird um 11:00 MEZ per Webcast abgehalten, und der Geschäftsabschluss der Fusion wird voraussichtlich kurz nach der Genehmigung abgeschlossen sein, vorbehaltlich Abschlussbedingungen.
Terra Innovatum، مطوِّر مفاعلات نووية ميكرو-مودولار، وGSR III Acquisition Corp. (NASDAQ: GSRT)أعلنا أن هيئة الأوراق المالية والسلع الأمريكية (SEC) أعلنت سريان بيان تسجيل S-4 الخاص بهما لصفقة الدمج المقترحة. لقد حددت الشركات اجتماع الجمعية العامة غير العادي في 7 أكتوبر 2025 للموافقة على الاندماج.
قدم Terra Innovatum تقدمًا مهمًا، بما في ذلك تأمين اتفاقيات تفاهم لتوريد مكونات نووية وتصنيعها، واختيار أول موقع للنشر، والتقدم بإجراءات NRC. تاريخ السجل لتصويت المساهمين هو 15 سبتمبر 2025، وأوصى مجلس GSRT بالإجماع بالتصويت لصالح جميع المقترحات.
ستعقد الجلسة الافتراضية في الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة عبر البث المباشر، ومن المتوقع أن تتم الصفقة قريبا من الموافقة، رهناً بشروط الإغلاق.
Terra Innovatum，一家微模块化核反应堆开发商，和GSR III Acquisition Corp.（NASDAQ: GSRT）宣布，SEC已宣布其S-4注册声明就拟议的商业合并生效。这些公司已安排在2025年10月7日举行非常股东大会以批准合并。
Terra Innovatum取得了重大进展，包括就核部件供应与制造取得谅解备忘录、选定首个部署地点，并推进NRC程序。股东投票的记录日期为2025年9月15日，GSRT董事会一致建议对所有提案投赞成票。
虚拟会议将于美东时间11:00进行，通过 webcast 直播，预计在批准后不久完成合并，须符合收盘条件。
- SEC declared S-4 registration statement effective, clearing a major regulatory hurdle
- Company has secured MOUs for supply and manufacturing of all major nuclear components
- First deployment site has been selected
- Strong early customer interest demonstrated through order MOUs
- Significant progress made with Nuclear Regulatory Commission (NRC)
- Transaction completion still subject to shareholder approval and closing conditions
- No specific financial terms or valuation details disclosed
Insights
Terra Innovatum's SPAC merger with GSRT advances with SEC approval of S-4 registration, shareholder vote scheduled for October 7.
The announcement marks a critical milestone in the SPAC merger process between Terra Innovatum and GSR III Acquisition Corp. The SEC's declaration of effectiveness for the S-4 registration statement on September 12 officially clears the regulatory hurdle necessary to proceed to the shareholder vote phase. This development indicates the transaction is progressing on schedule, with the extraordinary general meeting set for October 7, 2025.
The management commentary reveals significant operational progress at Terra Innovatum, including securing memoranda of understanding for component supply and manufacturing, selecting their first deployment site, generating customer interest through order MOUs, and advancing regulatory work with the Nuclear Regulatory Commission. These developments strengthen Terra Innovatum's business case ahead of the shareholder vote.
For GSRT shareholders, this announcement initiates the formal proxy voting process. All shareholders of record as of September 15, 2025, will receive voting materials and can participate in the October 7 virtual meeting. The board's unanimous recommendation to vote "FOR" the transaction signals confidence in the deal's structure and valuation. The clear timeline provided—with the meeting date and anticipated closing shortly thereafter—offers investors a concrete schedule for this liquidity event, assuming shareholder approval and satisfaction of other closing conditions.
Extraordinary General Meeting of Shareholders to be Held on October 7, 2025
NEW YORK and AUSTIN, Texas, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. ("GSRT") (Nasdaq: GSRT), a publicly traded special purpose acquisition company, today announced that on September 12, 2025, the U.S. Securities and Exchange Commission (“SEC”) declared effective the registration statement on Form S-4, as amended (the “Registration Statement”), in connection with the previously announced proposed business combination between Terra Innovatum and GSRT.
Alessandro Petruzzi, Co-Founder & CEO of Terra Innovatum commented: "The effectiveness of our S-4 is a major step towards bringing Terra Innovatum to the public markets. In the last several months, we’ve built a strong foundation to support the commercialization of our micro-modular reactors: signed MOUs for the supply and manufacture of every major nuclear component for our reactors, selected our first deployment site, generated strong early customer interest through order MOUs, and significantly advanced our progress with the NRC. With the proceeds from this transaction, we will be positioned to accelerate our mission to deliver low-cost, zero-carbon, and reliable energy where it’s needed most.”
Extraordinary General Meeting of Shareholders Details
GSR III Acquisition Corp. will hold its extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) on October 7, 2025, at 11:00 a.m., Eastern Time, to approve the business combination with Terra Innovatum and related matters. GSRT shareholders of record as of September 15, 2025, are entitled to vote at the Extraordinary General Meeting and will receive by mail a definitive proxy statement/prospectus (the "Proxy Statement") with instructions on how to vote their shares.
The GSRT Board of Directors unanimously recommends that shareholders vote "FOR" the transaction proposal as well as for the other proposals that are set forth in the Proxy Statement. Every shareholder’s vote FOR ALL the proposals that will be included in the Proxy Statement is important, regardless of the number of shares held.
The Extraordinary General Meeting will be held virtually and conducted via live webcast at https://www.cstproxy.com/gsriii/2025. Only GSRT shareholders at the close of business on the record date may vote at the Extraordinary General Meeting or any adjournment thereof. GSRT shareholders are entitled to one vote on each proposal presented at the Extraordinary General Meeting for each GSR III Ordinary Share held on the record date.
GSRT shareholders who need assistance voting, have questions regarding the Extraordinary General Meeting, or would like to request documents may contact GSRT’s proxy solicitor Sodali & Co. at (800) 662-5200 (banks and brokers can call (203) 658-9400) or by emailing GSRT.info@investor.sodali.com.
If the necessary proposals at the Extraordinary General Meeting are approved, Terra Innovatum and GSRT anticipate that the business combination will close shortly after the Extraordinary General Meeting, subject to the satisfaction of all other closing conditions.
ABOUT GSR III
GSR III Acquisition Corp. is a blank check company incorporated in the Cayman Islands with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating businesses. GSRT is led by a highly experienced sponsor team with a strong track record in SPAC transactions, having previously sponsored two SPACs and advised on over 20 successful SPAC completions. The company's management team includes Co-Chief Executive Officers Mr. Gus Garcia and Mr. Lewis Silberman, President and Chief Financial Officer Mr. Anantha Ramamurti, and Chief Business Development Officer Mr. Yuya Orime.
ABOUT TERRA INNOVATUM & SOLOTM
Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time.
Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.
It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.
SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.
To learn more, visit: www.terrainnovatum.com.
CONTACTS
Giordano Morichi
Partner, Chief Business Development Officer & Investor Relations
Terra Innovatum Srl
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com
Anantha Ramamurti
President, Chief Financial Officer
GSR III Acquisition Corp
E: anantha@gsrspac.com
P: (949) 468-7434
Nicholas Hresko-Staab
Vice President
Investor & Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com
IMPORTANT INFORMATION FOR SHAREHOLDERS
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.
PARTICIPANTS IN THE SOLICITATION
Each of the Registrant Parties, and their respective directors and executive officers, may be considered participants in the solicitation of proxies with respect to the potential transaction described in this communication under the rules of the SEC. Information about the directors and executive officers of GSRT is set forth in GSRT’s filings with the SEC. Information regarding other persons who may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with the potential transaction and a description of their direct and indirect interests will be set forth in the Registration Statement (and will be included in the proxy statement/prospectus) and other relevant documents when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above.
FORWARD LOOKING STATEMENTS
The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on GSRT and the other Registrant Parties. There can be no assurance that future developments affecting GSRT and the other Registrant Parties will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the Business Combination; (2) the outcome of any legal proceedings that may be instituted against GSRT, any of the Registrant Parties, the combined company or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of GSRT or the SEC’s declaration of the effectiveness of the Registration Statement (which will include the proxy statement/prospectus contained therein) to be filed by the Registrant Parties or to satisfy other conditions to closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (5) the ability of Pubco to meet stock exchange listing standards following the consummation of the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations of Terra Innovatum as a result of the announcement and consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Business Combination, including the reorganization described in the business combination agreement; (9) changes in applicable laws or regulations; (10) the possibility that the Registrant Parties or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the amount of redemption requests made by GSRT shareholders and (12) other risk factors described herein as well as the risk factors and uncertainties described in the Form S-4 and GSRT’s other filings with the SEC, as well as any further risks and uncertainties to be contained in the proxy statement/prospectus filed after the date hereof. In addition, there may be additional risks that neither GSRT nor any of the other Registrant Parties presently know, or that GSRT or the other Registrant Parties currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
None of GSRT, the other Registrant Parties, or any of their respective affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. GSRT, the other Registrant Parties and their respective affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom. Further, the information contained herein is preliminary, is provided for discussion purposes only, is only a summary of key information, is not complete and is subject to change without notice.
In addition, the information contained in this press release is provided as of the date hereof and may change, and neither GSRT nor the other Registrant Parties undertakes any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.
FAQ
When is the Terra Innovatum and GSRT (NASDAQ:GSRT) merger vote scheduled?
What is the record date for GSRT shareholders to vote on the Terra Innovatum merger?
What progress has Terra Innovatum made in its nuclear reactor development?
How can GSRT shareholders vote on the Terra Innovatum merger?
What is Terra Innovatum's business focus?
